This well though out, step-wise approach allowed us to identify a candidate to be tested in the 56-sample study to determine whether methylation of the ACSL3 5′CGI could be a stand alone biomarker for PAH exposure and/or PAH-associated childhood asthma. The gene discussed is ACSL3; the disease is asthma.